Prognosis of stage III colorectal carcinomas with FOLFOX adjuvant chemotherapy can be predicted by molecular subtype

Individualizing adjuvant chemotherapy is important in patients with advanced colorectal cancers (CRCs), and the ability to identify molecular subtypes predictive of good prognosis for stage III CRCs after adjuvant chemotherapy could be highly beneficial. We performed microarray-based gene expression...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Kwon, Yujin, Park, Minhee, Jang, Mi, Yun, Seongju, Kim, Won Kyu, Kim, Sora, Paik, Soonmyung, Lee, Hyun Jung, Hong, Sungpil, Kim, Tae Il, Min, Byungsoh, Kim, Hoguen
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2017
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5503619/
https://ncbi.nlm.nih.gov/pubmed/28455965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17023
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi